Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bloomfield

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|July 13, 2017
Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart FailureKevin Damman, Mattia A E Valente, Dirk J van Veldhuisen, et al.
Journal of the American College of Cardiology|September 19, 2003
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonistEric N Prystowsky, Imran Niazi, Anne B Curtis, et al.
Lancet (London, England)|December 11, 2007
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studiesRajesh Krishna, Matt S Anderson, Arthur J Bergman, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
European Journal of Heart Failure|April 27, 2016
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortalityBeth A Davison, Marco Metra, Stefanie Senger, et al.
Circulation. Heart Failure|May 12, 2018
Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT DataMarco Metra, Gad Cotter, Stefanie Senger, et al.
European Heart Journal|March 11, 2011
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT StudyMarco Metra, Christopher M O'Connor, Beth A Davison, et al.
The New England Journal of Medicine|October 8, 2010
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failureBarry M Massie, Christopher M O'Connor, Marco Metra, et al.
Psychopharmacology|November 10, 2017
Psilocybin with psychological support for treatment-resistant depression: six-month follow-upR L Carhart-Harris, M Bolstridge, C M J Day, et al.
The International Journal of Neuropsychopharmacology|December 19, 2013
The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memoriesR L Carhart-Harris, M B Wall, D Erritzoe, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|July 13, 2017
Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart FailureKevin Damman, Mattia A E Valente, Dirk J van Veldhuisen, et al.
Journal of the American College of Cardiology|September 19, 2003
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonistEric N Prystowsky, Imran Niazi, Anne B Curtis, et al.
Lancet (London, England)|December 11, 2007
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studiesRajesh Krishna, Matt S Anderson, Arthur J Bergman, et al.
International Journal of Cardiology|December 16, 2015
Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patientsBiniyam G Demissei, John G Cleland, Christopher M O'Connor, et al.
European Journal of Heart Failure|April 27, 2016
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortalityBeth A Davison, Marco Metra, Stefanie Senger, et al.
Circulation. Heart Failure|May 12, 2018
Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT DataMarco Metra, Gad Cotter, Stefanie Senger, et al.
European Heart Journal|March 11, 2011
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT StudyMarco Metra, Christopher M O'Connor, Beth A Davison, et al.
The New England Journal of Medicine|October 8, 2010
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failureBarry M Massie, Christopher M O'Connor, Marco Metra, et al.
Psychopharmacology|November 10, 2017
Psilocybin with psychological support for treatment-resistant depression: six-month follow-upR L Carhart-Harris, M Bolstridge, C M J Day, et al.
The International Journal of Neuropsychopharmacology|December 19, 2013
The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memoriesR L Carhart-Harris, M B Wall, D Erritzoe, et al.
Pageof 19